Clinical trials
Vascular Diseases trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 4 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 3 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Active, not recruiting | 5 |
| Recruiting | 3 |
| Unknown status | 3 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 10 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2 |
| Bayer | 2 |
| Medtronic Vascular | 2 |
| ReCor Medical, Inc. | 2 |
| Takeda | 2 |
| UMC Utrecht | 2 |
| United Therapeutics | 2 |
| Wageningen University | 2 |
| Amarin Pharma Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vascular Diseases | 44 |
| Cardiovascular Diseases | 24 |
| Myocardial Ischemia | 15 |
| Coronary Artery Disease | 13 |
| Coronary Disease | 10 |
| Coronary Stenosis | 10 |
| Coronary Restenosis | 9 |
| Heart Diseases | 9 |
| Hypertension | 9 |
| Embolism and Thrombosis | 6 |
Trials
Showing 51 to 44 of 44. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.